This literature review illustrates the possibilities of GPCR monitoring with HTRF second messenger cAMP and IP-1 assays in a cardiovascular context. It features experiments and data from published studies that investigated b-arrestin-biased ligands of the angiotensin II and apelin receptors, as well as inhibitor screening of the relaxin receptor and atrial natriuretic peptide signaling through ANPRs.
Features